Morning Overview on MSN
Two new pancreatic cancer treatments — a targeted pill and a personalized mRNA vaccine — are beating back one of medicine’s deadliest tumors in early trials
Pancreatic cancer has long been oncology’s most stubborn adversary. Fewer than 13% of patients survive five years after ...
According to our partners at Louisville Business First, Dr. Mark Lynn of Lynn Family Vision and his business partner, Jimmy ...
Strong Buy on DM1 & DMD clinical progress, BLA timeline, and strong cash runway through 2028. Click for this DYN update.
A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and ...
There is a version of this story that ends well.A class of molecules with genuine biological potential, freed from ...
The FDA has granted Coya 302 a fast-track designation for ALS, according to a press release from Coya Therapeutics. “ALS is a ...
The FDA commissioner influences vaccines, medicines, food safety, nicotine regulation, and public trust. Here’s how ...
FDA Breakthrough Designation -- CardiAMP Cell Therapy for ischemic heart failure holds FDA breakthrough status and is ...
For manufacturers, medical device companies, and laboratories that use the commercial diagnostic tests they produce, ...
Las Vegas-based tech startup Regara can cut the time-consuming FDA approval process in half, which, for a drug like Ozempic, ...
8d
Trump’s flavored vape push sparks backlash from some MAHA influencers and administration officials
The FDA this month opened a pathway for tobacco companies to sell flavored e-cigarettes and granted its first authorization ...
Access to mifepristone, approved by FDA in 2000, is regulated by a "Risk Evaluation and Management Strategy" (REMS). Under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results